All In Biotech

Free tool

FAERS Monitor: Retin-A

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017579 or its brand name (Retin-A, Tretinoin). Reports on generic versions are filed under their own applications.

Reports

7,845

Serious

4,769

61% of reports

Hospitalization

1,657

Death reported

882

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use964
  • drug ineffective810
  • pain585
  • product use in unapproved indication509
  • vomiting504
  • nausea441
  • rash433
  • headache426
  • diarrhoea411
  • paraesthesia396
  • abdominal pain upper386
  • fatigue369
  • hypoaesthesia363
  • drug intolerance346
  • maternal exposure during pregnancy344

Reports by year received

View as table
YearReports
200447
200547
200636
200752
2008135
200999
2010110
2011158
2012198
2013117
2014175
2015312
2016528
2017478
2018533
2019455
2020445
2021453
2022576
2023644
2024758
2025886
2026603

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,314 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
maternal exposure during pregnancySignal34410.49.42,909
drug intoleranceSignal3469.68.72,671
paraesthesiaSignal3966.86.11,949
hypoaesthesiaSignal3636.55.91,697
product use in unapproved indicationSignal5095.55.11,896
abdominal pain upperSignal3865.04.61,254
off label useSignal9643.02.81,296
vomitingSignal5042.92.6628
rashSignal4332.72.4458
painSignal5852.62.4568
headache4261.81.7162
diarrhoea4111.71.6123
drug ineffective8101.61.5219
nausea4411.51.474
fatigue3691.31.222

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.